GlassScriptPhysician profile
Sydni Crowell
NPI 1851825715
$1,253.26
in general payments reported to CMS, 2019-2025
22 companies · $247 in 2025
The $247 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $344 · 2022: $16.28 · 2023: $121 · 2024: $525 · 2025: $247.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $893.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $892.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $341.28 | 2019-2022 | |
| Biogen, INC. | $156.06 | 2024-2025 | Zurzuvae |
| Sumitomo Pharma America, INC. | $114.45 | 2023-2025 | Myfembree, Gemtesa |
| Shield Therapeutics INC | $69.93 | 2023-2024 | Accrufer |
| Novo Nordisk INC | $62.68 | 2023-2024 | Wegovy |
| Axonics, INC. | $60.88 | 2024 | Bulkamid, Axonics |
| Organon LLC | $59.19 | 2024 | |
| Hologic Sales and Service, LLC | $55.48 | 2024-2025 | Aptima, Novasure, Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Abbvie INC. | $42.94 | 2024 | |
| Gynesonics, INC. | $42.78 | 2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Becton, Dickinson and Company | $40.04 | 2024 | |
| Astellas Pharma US INC | $35.87 | 2024 | Veozah |
| Innovation Technologies INC | $24.11 | 2025 | Irrisept |
| Coloplast Corp | $19.42 | 2024 | |
| Merck Sharp & Dohme LLC | $19.26 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $17.87 | 2023 | Da Vinci Surgical System |
| Amgen INC. | $17.41 | 2023 | Prolia, Evenity |
| Coopersurgical, INC. | $15.59 | 2025 | Endosee |
| Medtronic, INC. | $15.22 | 2024 | Ligasure |
| Minerva Surgical, INC | $14.52 | 2025 | |
| Lilly USA, LLC | $14.33 | 2024 | Zepbound, Jardiance |
| Currax Pharmaceuticals LLC | $13.95 | 2024 | Contrave |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sydni Crowell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.